Meeting
2014 ASCO Annual Meeting
The 12-gene colon cancer assay validation and utility: Summary of clinical evidence.
Authors
Emily Burke
Genomic Health, Inc., Redwood City, CA
Emily Burke , Haluk Tezcan , Margarita Lopatin , Kim Michelle Clark-Langone , Mark Lee , Steven Shak , Amy P. Sing
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 3547)
DOI
10.1200/jco.2014.32.15_suppl.3547
Abstract #
3547
Poster Bd #
10
Abstract Disclosures
Similar Posters
Poster
2014 Gastrointestinal Cancers Symposium
The 12-gene colon cancer assay validation and utility: Summary of clinical evidence.
First Author: Emily Burke
Poster
2019 Gastrointestinal Cancers Symposium
The effect of adjuvant chemotherapy for stage III colon cancer in elderly patients.
First Author: Naomi Hayashi
Poster
2014 ASCO Annual Meeting
Sustaining quality cancer care in the NCI Community Cancer Centers Program (NCCCP).
First Author: Kathleen M. Castro
Poster
2024 ASCO Annual Meeting
Early versus conventional adjuvant chemotherapy in stage III colon cancer: A multicenter, randomized, open-label, phase 3 trial.
First Author: Soo Yeun Park